Funding for this research was provided by:
Seventh Framework Programme (FP7/2007–2013)
Text and Data Mining valid from 2016-11-05
Received: 27 June 2016
Accepted: 3 October 2016
First Online: 5 November 2016
Compliance with ethical standards
: The research leading to these results has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement no. 115008 of which resources are composed of EFPIA in kind contribution and financial contribution from the European Union’s Seventh Framework Programme (FP7/2007–2013).
: Author L.F. is employed part time at the AstraZeneca PET Science Center at Karolinska Institutet. Authors J.N., C.B. and B.B.A. are full time employees of H. Lundbeck A/S, and author S.G. is a full time employee of Pfizer Inc. The authors K.C.Y, V.S., N.A., S.M., A.T., C.H. and S.J.F. declare that they have no conflict of interest.
: The study was approved by the Animal Research Ethical Committee of the Northern Stockholm region (Dnr N452/11, N632/12, N633/12 and N185/14). All applicable international, national, and/or institutional guidelines for the care and use of animals were followed.